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Abstract
To investigate West Nile virus (WNV) circulation in rural populations in Gabon, we undertook a large serological survey 
focusing on human rural populations, using two different ELISA assays. A sample was considered positive when it 
reacted in both tests. A total of 2320 villagers from 115 villages were interviewed and sampled. Surprisingly, the WNV-
specific IgG prevalence was high overall (27.2%) and varied according to the ecosystem: 23.7% in forested regions, 
21.8% in savanna, and 64.9% in the lakes region. The WNV-specific IgG prevalence rate was 30% in males and 24.6% in 
females, and increased with age. Although serological cross-reactions between flaviviruses are likely and may be 
frequent, these findings strongly suggest that WNV is widespread in Gabon. The difference in WNV prevalence among 
ecosystems suggests preferential circulation in the lakes region. The linear increase with age suggests continuous 
exposure of Gabonese populations to WNV. Further investigations are needed to determine the WNV cycle and 
transmission patterns in Gabon.
Findings
West Nile virus (WNV) is a mosquito-borne RNA virus
belonging to the genus Flavivirus, family Flaviviridae.
Although human WNV infection is generally asymptom-
atic or causes a 'flu-like illness, life-threatening neurolog-
ical complications such as meningoencephalitis and
flaccid paralysis have been reported [1]. WNV is trans-
mitted in the wild through an enzootic cycle involving
birds and ornithophilic mosquitoes [2,3]. WNV has been
widely reported thorough the world, including in many
African countries [2,4]. However, the distribution of
WNV is poorly documented in central Africa. Serological
evidence of human exposure to WNV has been reported
in the Central African Republic [5], Cameroon [6] and the
Democratic Republic of Congo [7], with IgG prevalence
rates ranging from 6.6% to 59%. The human WNV IgG
prevalence has not been investigated in Gabon. The
recent occurrence of a human case with neurological
manifestations in Libreville [8] during concomitant chi-
kungunya and dengue outbreaks [9], as well as the detec-
tion of specific IgG in horses in some Gabonese cities
[10], led us to assess the circulation of WNV in Gabon.
We undertook a large serological survey focusing on rural
human population and using two ELISA assays: a com-
mercial indirect West Nile virus IgG kit (Panbio diagnos-
tics, Australia) and an ELISA method that has been
extensively validated against a serum neutralisation test
[11]. We considered as WNV IgG-positive all samples
reacting in the two ELISA tests.
A total of 2320 villagers were interviewed, of whom
1869 (80%) lived in forested regions, 243 (11%) in savan-
nas, and 208 (9%) in the lakes region (Table 1). The
WNV-specific IgG prevalence was 27.2% overall (631/
2320), 23.7% (443/1869) in the forests, 21.8% (53/243) in
the savannas, and 64.9% (135/208) in the lakes region
(Figure 1). The villager sample comprised 47.2% of males
(1096/2320) and 52.8% of females (1224/2320), and the
corresponding WNV IgG prevalence rates were respec-
tively 30% (329/1096) and 24.6% (302/1224). The WNV
IgG prevalence rate increased with age from 20.1% (119/
591) in the 13-35 year age group to 30.7% (177/576) in the
over-60 age group.
Surprisingly, the overall WNV-specific IgG prevalence
was high, at levels similar to those found in countries hit
by outbreaks. During the WNV outbreaks that occurred
in Sudan in 1898 [12] and in the Democratic Republic of
Congo (DRC) in 1988 [7], WNV-specific IgG was found
in respectively 59% and 66% of subjects (both IgG and
IgM in DRC). During interepidemic periods in Egypt in
1991 [13], Uganda in 1984 [14], and the Central African
Republic (CAR) in 1975 [15] and 1979 [16], the WNV-
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specific IgG prevalence rates were respectively 20%, 16%,
3% and 55%. In countries with no reported clinical cases
or WNV isolation, WNV-specific IgG prevalence rates
ranged from 0.9% in Kenya in 1987 [17] to 6.6% in Cam-
eroon in 2000 [6] and 27.9% in Ghana in 2008 [18]. The
high WNV-specific IgG prevalence detected in this sur-
vey suggests that this virus circulates actively in Gabon,
despite the lack of reported clinical cases and the low
prevalence (about 3%, 2/64) [10] detected in horses sam-
pled in three Gabonese cities. This surprising result may
be explained by several factors. Firstly, WNV-specific IgG
might arise from aborted WNV infection and antigenic
stimulation. Secondly, the lack of reported WNV out-
breaks or even isolated cases could be due to the circula-
tion of less virulent WNV strains. Clinical cases may be
misdiagnosed and attributed to a similar disease such as
malaria or another arbovirosis [19]. Finally, positive serol-
ogies might be due to cross-reactions with dengue or yel-
low fever antibodies, as IgG cross-reactions between
flaviviruses have been extensively described in other
studies [20,21] and these viruses are known to circulate in
several regions of Gabon [9,22].
These preliminary results strongly suggest that WNV
circulation is widespread in Gabon. The linear increase in
WNV IgG prevalence with age suggests continuous expo-
s u r e  o f  G a b o n e s e  p o p u l a t i o n s  t o  t h i s  v i r u s.  M o r e o v e r ,
although serological cross-reactions due to non specific
WNV antibodies could not been ruled out, the larger dif-
ference in the prevalence rates between the different eco-
systems suggests preferential WNV circulation in the
lakes region. This may be explained by specific ecological
features such as mosquito vector species or a higher den-
sity of residental and migratory birds [23].
In conclusion, this first serological survey of West Nile
virus in Gabonese human populations shows widespread
circulation of this virus. Further investigations are
needed to determine the WNV cycle and transmission
patterns in Gabon.
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Table 1: West Nile fever virus-specific IgG prevalence according to villagers' sex and age and the ecosystem.
Characteristics Variable Number of Subjects (%) IgG + (%) 95% CI
All participants 2320 (100) 631 (27.2) 25.4-29.1
Ecosystem
Forest 1869 (80) 443 (23.7) 21.8-25.7
Savanna 243 (11) 53 (21.8) 16.8-27.5
Lakes 208 (9) 135 (64.9) 58-71.4
Sex Male 1096 (47.2) 329 (30) 27.3-32.7
Female 1224 (52.8) 302 (24.6) 22.5-27.1
Age 15-35 591 (25.5) 119 (20.1) 16.9-23.3
36-50 596 (25.7) 167 (28) 24.4-31.6
51-60 557 (24) 168 (30.1) 26.4-37.4
>60 576 (24.8) 177 (30.7) 26.9-34.5
Figure 1 Location of the Gabonese villages sampled in the forest 
(green), savanna (yellow) and lakes (brown) regions and corre-
sponding WNV IgG prevalence levels (blue circles).Pourrut et al. Virology Journal 2010, 7:132
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